U.S. pharma big copyright scrapped two experimental weight loss tablets past calendar year—a as soon as-day-to-day tablet, lotiglipron, resulting from elevated liver enzymes along with a two times-each day capsule, danuglipron, resulting from potent Unwanted side effects—but CEO Albert Bourla has explained the company is determined to “Enjoy